{"context":{"query":">>efo>>gwas","source_dataset":"efo","target_dataset":"gwas"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]EFO:0000305,72,EFO:0000305,158,1]["},"schema":"id|disease_trait|mapped_gene|chr_id|p_value","mappings":[{"input":"EFO:0000305","source":"EFO:0000305|breast carcinoma","targets":["GCST000035_1|Breast cancer|CASC16|16|1.000000e-36","GCST000035_2|Breast cancer|FGFR2|10|2.000000e-76","GCST000035_3|Breast cancer|CASC8, POU5F1B, PCAT1|8|5.000000e-12","GCST000035_4|Breast cancer|HCN1|5|9.000000e-06","GCST000035_5|Breast cancer|C5orf67 - MAP3K1|5|7.000000e-20","GCST000035_6|Breast cancer|LSP1|11|3.000000e-09","GCST000036_1|Breast cancer|FGFR2|10|1.000000e-10","GCST000037_1|Breast cancer|TESHL|2|1.000000e-13","GCST000037_2|Breast cancer|CASC16|16|6.000000e-19","GCST000079_1|Breast cancer|LINC01122|2|5.000000e-06","GCST000079_2|Breast cancer|FBN1|15|6.000000e-06","GCST000079_3|Breast cancer|LINC02444 - LINC02882|12|7.000000e-07","GCST000079_4|Breast cancer|LINC01905, LINC01416|18|1.000000e-06","GCST000079_5|Breast cancer|STAG3L4 - MTATP6P21|7|3.000000e-06","GCST000079_6|Breast cancer|COL1A1|17|8.000000e-08","GCST000079_7|Breast cancer|GRIK1|21|6.000000e-06","GCST000079_8|Breast cancer|LINC03000, LINC02143|5|5.000000e-07","GCST000079_9|Breast cancer|ABCC4|13|2.000000e-06","GCST000162_1|Breast cancer|RNF146|6|3.000000e-08","GCST000187_1|Breast cancer|CLEC18B - GLG1; No mapped genes; No mapped genes|16|4.000000e-07","GCST000343_1|Breast cancer|CCDC170 - ESR1|6|2.000000e-15","GCST000365_1|Breast cancer|C5orf67 - MAP3K1|5|5.000000e-07","GCST000365_2|Breast cancer|EMBP1, EMBP1|1|7.000000e-10","GCST000365_3|Breast cancer|RAD51B|14|2.000000e-07","GCST000365_4|Breast cancer|TESHL|2|2.000000e-08","GCST000365_5|Breast cancer|CASC16|16|1.000000e-09","GCST000365_6|Breast cancer|FGFR2|10|2.000000e-10","GCST000678_1|Breast cancer|C5orf67 - MAP3K1|5|5.000000e-09","GCST000678_10|Breast cancer|CASC16|16|3.000000e-15","GCST000678_11|Breast cancer|CCDC170|6|3.000000e-06","GCST000678_12|Breast cancer|GDI2 - ANKRD16|10|5.000000e-07","GCST000678_13|Breast cancer|LINC01488 - PNCRNA-D|11|3.000000e-15","GCST000678_2|Breast cancer|FGFR2|10|4.000000e-31","GCST000678_3|Breast cancer|ZNF365 - LINC02929|10|5.000000e-15","GCST000678_4|Breast cancer|POU5F1B, PCAT1, CASC8|8|6.000000e-07","GCST000678_5|Breast cancer|TESHL|2|2.000000e-10","GCST000678_6|Breast cancer|TNNT3|11|7.000000e-07","GCST000678_7|Breast cancer|SLC4A7|3|6.000000e-07","GCST000678_8|Breast cancer|CDKN2B-AS1|9|3.000000e-08","GCST000678_9|Breast cancer|ZMIZ1|10|4.000000e-09","GCST000709_1|Breast cancer|CASC16|16|1.000000e-28","GCST000801_1|Breast cancer|BABAM1, USHBP1|19|2.000000e-09","GCST000811_1|Breast cancer|CASC16|16|4.000000e-07","GCST000811_2|Breast cancer|MRPS30 - HCN1|5|7.000000e-07","GCST000811_3|Breast cancer|TESHL|2|9.000000e-06","GCST000811_4|Breast cancer|FGFR2|10|2.000000e-13","GCST000846_1|Breast cancer in BRCA2 mutation carriers|FGFR2|10|1.000000e-08","GCST000952_1|Breast cancer|TESHL|2|2.000000e-10","GCST000952_2|Breast cancer|SLC4A7|3|2.000000e-08","GCST000952_3|Breast cancer|POU5F1B, PCAT1, CASC8|8|3.000000e-11","GCST000952_4|Breast cancer|CASC16|16|4.000000e-10","GCST000952_5|Breast cancer|CCDC170|6|1.000000e-07","GCST000952_6|Breast cancer|ATE1|10|2.000000e-06","GCST000952_7|Breast cancer|MRPS30-DT|5|8.000000e-11","GCST000952_8|Breast cancer|FGFR2|10|1.000000e-30","GCST000952_9|Breast cancer|CHCHD4P2 - RPL36P14|9|2.000000e-10","GCST001012_1|Breast cancer|ROPN1L|5|2.000000e-06","GCST001012_2|Breast cancer|ZNF577|19|7.000000e-06","GCST001224_1|Breast cancer|LINC-PINT|7|6.000000e-06","GCST001224_2|Breast cancer|ZNF365 - LINC02929|10|6.000000e-09","GCST001298_1|Breast cancer|TERT|5|1.000000e-10","GCST001373_1|Breast cancer (survival)|ZFHX3, LOHAN2|16|6.000000e-06","GCST001373_2|Breast cancer (survival)|RAD51B|14|1.000000e-07","GCST001373_3|Breast cancer (survival)|RAD51B|14|3.000000e-07","GCST001420_1|Breast cancer|TAB2|6|4.000000e-12","GCST001420_2|Breast cancer|ESR1|6|2.000000e-06","GCST001420_3|Breast cancer|RPS27P20 - LINC01395|11|5.000000e-07","GCST001457_1|Breast cancer|ERBB4|2|9.000000e-14","GCST001489_1|Percent mammographic density|TBX5-AS1 - RN7SKP216|12|1.000000e-08","GCST001648_1|Breast cancer|LINC02330 - GALC|14|4.000000e-06","GCST001667_1|Breast cancer|ERICH6-AS1, SIAH2|3|9.000000e-08","GCST001667_2|Breast cancer|FGFR2|10|8.000000e-08","GCST001683_1|Breast cancer|USHBP1, ANKLE1|19|4.000000e-08","GCST001683_2|Breast cancer|ESR1|6|2.000000e-10","GCST001683_3|Breast cancer|RALY|20|1.000000e-08","GCST001683_4|Breast cancer|RPSAP72 - TENT5A|6|3.000000e-07","GCST001816_1|Breast cancer (prognosis)|SYT6|1|8.000000e-06","GCST001816_2|Breast cancer (prognosis)|PBX1|1|4.000000e-06","GCST001816_3|Breast cancer (prognosis)|PCBP2P3 - LDHBP3|5|1.000000e-06","GCST001816_4|Breast cancer (prognosis)|RORA - LINC02349|15|4.000000e-06","GCST001816_5|Breast cancer (prognosis)|NTN1|17|8.000000e-06","GCST001831_1|Breast cancer|LNC-LBCS|6|2.000000e-06","GCST001831_2|Breast cancer|ADAMTS7P3|15|7.000000e-07","GCST001831_3|Breast cancer|FGFR2|10|2.000000e-06","GCST001879_1|Breast cancer|RAD51B; RAD51B; RAD51B; RAD51B; RAD51B; RAD51B|14;14;14;14;14;14|2.000000e-06","GCST001879_10|Breast cancer|TNIP3; TNIP3|4;4|2.000000e-06","GCST001879_11|Breast cancer|ADAMTS16 - ALG3P1; ADAMTS16|5;5|3.000000e-06","GCST001879_12|Breast cancer|PLXNC1; RN7SKP263 - PLXNC1|12;12|5.000000e-06","GCST001879_13|Breast cancer|BCAS3; BCAS3|17;17|8.000000e-06","GCST001879_2|Breast cancer|TNIP3; TNIP3|4;4|3.000000e-07","GCST001879_3|Breast cancer|SLC45A1; SLC45A1; SLC45A1; SLC45A1; SLC45A1|1;1;1;1;1|5.000000e-06","GCST001879_4|Breast cancer|LASTR; LASTR; LASTR|10;10;10|5.000000e-06","GCST001879_5|Breast cancer|ZMIZ1|10|6.000000e-06","GCST001879_6|Breast cancer|SLC45A1; SLC45A1|1;1|5.000000e-06","GCST001879_7|Breast cancer|GRM7; GRM7|3;3|3.000000e-06","GCST001879_8|Breast cancer|TNIP3; TNIP3|4;4|2.000000e-06","GCST001879_9|Breast cancer|TNIP3; TNIP3|4;4|2.000000e-06","GCST001916_1|Breast Cancer in BRCA1 mutation carriers|CCDC170 - ESR1|6|5.000000e-09","GCST001916_2|Breast Cancer in BRCA1 mutation carriers|PTHLH - CCDC91|12|8.000000e-06","GCST001916_3|Breast Cancer in BRCA1 mutation carriers|MDM4|1|1.000000e-07"]}]}